Literature DB >> 14603323

Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage.

Luca Busino1, Maddalena Donzelli, Massimo Chiesa, Daniele Guardavaccaro, Dvora Ganoth, N Valerio Dorrello, Avram Hershko, Michele Pagano, Giulio F Draetta.   

Abstract

The Cdc25A phosphatase is essential for cell-cycle progression because of its function in dephosphorylating cyclin-dependent kinases. In response to DNA damage or stalled replication, the ATM and ATR protein kinases activate the checkpoint kinases Chk1 and Chk2, which leads to hyperphosphorylation of Cdc25A. These events stimulate the ubiquitin-mediated proteolysis of Cdc25A and contribute to delaying cell-cycle progression, thereby preventing genomic instability. Here we report that beta-TrCP is the F-box protein that targets phosphorylated Cdc25A for degradation by the Skp1/Cul1/F-box protein complex. Downregulation of beta-TrCP1 and beta-TrCP2 expression by short interfering RNAs causes an accumulation of Cdc25A in cells progressing through S phase and prevents the degradation of Cdc25A induced by ionizing radiation, indicating that beta-TrCP may function in the intra-S-phase checkpoint. Consistent with this hypothesis, suppression of beta-TrCP expression results in radioresistant DNA synthesis in response to DNA damage--a phenotype indicative of a defect in the intra-S-phase checkpoint that is associated with an inability to regulate Cdc25A properly. Our results show that beta-TrCP has a crucial role in mediating the response to DNA damage through Cdc25A degradation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14603323     DOI: 10.1038/nature02082

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  205 in total

1.  Coupled activation and degradation of eEF2K regulates protein synthesis in response to genotoxic stress.

Authors:  Flore Kruiswijk; Laurensia Yuniati; Roberto Magliozzi; Teck Yew Low; Ratna Lim; Renske Bolder; Shabaz Mohammed; Christopher G Proud; Albert J R Heck; Michele Pagano; Daniele Guardavaccaro
Journal:  Sci Signal       Date:  2012-06-05       Impact factor: 8.192

2.  Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism.

Authors:  Katsuhiro Uto; Daigo Inoue; Ken Shimuta; Nobushige Nakajo; Noriyuki Sagata
Journal:  EMBO J       Date:  2004-07-22       Impact factor: 11.598

Review 3.  Post-translational modifications in signal integration.

Authors:  Yonathan Lissanu Deribe; Tony Pawson; Ivan Dikic
Journal:  Nat Struct Mol Biol       Date:  2010-05-23       Impact factor: 15.369

4.  A novel mechanism of indole-3-carbinol effects on breast carcinogenesis involves induction of Cdc25A degradation.

Authors:  Yongsheng Wu; Xiaoling Feng; Yucui Jin; Zhaojia Wu; William Hankey; Carolyn Paisie; Lei Li; Fengjuan Liu; Sanford H Barsky; Weiwei Zhang; Ramesh Ganju; Xianghong Zou
Journal:  Cancer Prev Res (Phila)       Date:  2010-06-29

5.  PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A.

Authors:  Nikolaos Patsoukis; Duygu Sari; Vassiliki A Boussiotis
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

Review 6.  Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.

Authors:  H Christian Reinhardt; Michael B Yaffe
Journal:  Curr Opin Cell Biol       Date:  2009-02-21       Impact factor: 8.382

Review 7.  Regulation of DNA damage response pathways by the cullin-RING ubiquitin ligases.

Authors:  Jeffrey Hannah; Pengbo Zhou
Journal:  DNA Repair (Amst)       Date:  2009-02-23

8.  An SCF complex containing Fbxl12 mediates DNA damage-induced Ku80 ubiquitylation.

Authors:  Lisa Postow; Hironori Funabiki
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

Review 9.  In vivo roles of CDC25 phosphatases: biological insight into the anti-cancer therapeutic targets.

Authors:  Hiroaki Kiyokawa; Dipankar Ray
Journal:  Anticancer Agents Med Chem       Date:  2008-12       Impact factor: 2.505

10.  Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase.

Authors:  Ying Li; K G Kuresh Kumar; Weigang Tang; Vladimir S Spiegelman; Serge Y Fuchs
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.